Keeping Track: Scenesse, Reyvow, and Beovu Make Trio Of Novel Approvals
Executive Summary
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Patient-Focused Meeting On Vitiligo Could Galvanize R&D As The First Drug Candidates In A Long Time Advance
US FDA meeting directs attention to the vitiligo patient experience as a small group of potential treatments, led by topical Janus kinase inhibitors, are at the Phase II hinge point.
Keeping Track: A Good Week For Interstitial Lung Diseases; Opdivo+Yervoy Gains Liver Cancer Claim
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
March Madness: Upcoming US FDA Decision Dates To Watch
A dozen applications for new drugs and significant new indications are on the US FDA’s calendar of goal dates, including breakthrough-designated applications from Bristol-Myers Squibb and Boehringer Ingelheim.